VAERS reports by lot

Moderna COVID-19 lot 205E23A: VAERS reports

32 VAERS reports list lot 205E23A as a Moderna COVID-19 vaccine, received between 2023-09-22 and 2024-08-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
16%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular3924%
General / Systemic (non-local)3119%
Neurological2415%
Injection-site / Local reaction1610%
Gastrointestinal159%
Musculoskeletal138%
Respiratory127%
Thrombotic / Hematological74%
Autoimmune / Immune-mediated32%
Dermatological (non-injection-site)21%
Psychiatric / Neuropsychiatric21%
Allergic / Anaphylactic11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas7
Georgia3
South Carolina2
Wisconsin2
Michigan2
North Carolina2
Massachusetts2
New Jersey1
Kansas1
Pennsylvania1
Illinois1
Indiana1

Reports by month received

2023-099
2023-1014
2023-111
2023-124
2024-012
2024-061
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.